NO975023D0 - Vasoaktive cykliske polypeptider - Google Patents

Vasoaktive cykliske polypeptider

Info

Publication number
NO975023D0
NO975023D0 NO975023A NO975023A NO975023D0 NO 975023 D0 NO975023 D0 NO 975023D0 NO 975023 A NO975023 A NO 975023A NO 975023 A NO975023 A NO 975023A NO 975023 D0 NO975023 D0 NO 975023D0
Authority
NO
Norway
Prior art keywords
vasoactive
peptide
amino acid
chain
present
Prior art date
Application number
NO975023A
Other languages
English (en)
Other versions
NO975023L (no
Inventor
David Robert Bolin
Margaret O'donnell
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO975023L publication Critical patent/NO975023L/no
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO975023D0 publication Critical patent/NO975023D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO975023A 1991-10-11 1997-10-31 Vasoaktive cykliske polypeptider NO975023D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77374791A 1991-10-11 1991-10-11

Publications (2)

Publication Number Publication Date
NO975023L NO975023L (no) 1993-04-13
NO975023D0 true NO975023D0 (no) 1997-10-31

Family

ID=25099195

Family Applications (3)

Application Number Title Priority Date Filing Date
NO923929A NO304523B1 (no) 1991-10-11 1992-10-09 Vasoaktive cykliske polypeptider
NO975023A NO975023D0 (no) 1991-10-11 1997-10-31 Vasoaktive cykliske polypeptider
NO980377A NO980377D0 (no) 1991-10-11 1998-01-28 Vasoaktive cykliske peptider

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO923929A NO304523B1 (no) 1991-10-11 1992-10-09 Vasoaktive cykliske polypeptider

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO980377A NO980377D0 (no) 1991-10-11 1998-01-28 Vasoaktive cykliske peptider

Country Status (26)

Country Link
US (1) US5677419A (no)
EP (1) EP0536741B1 (no)
JP (1) JP2515473B2 (no)
KR (1) KR970001580B1 (no)
CN (3) CN1034943C (no)
AT (1) ATE132165T1 (no)
AU (1) AU656230B2 (no)
BG (1) BG61125B2 (no)
BR (1) BR9203959A (no)
CA (1) CA2080272C (no)
CZ (1) CZ281818B6 (no)
DE (1) DE69207138T2 (no)
DK (1) DK0536741T3 (no)
ES (1) ES2082317T3 (no)
FI (2) FI111646B (no)
GR (1) GR3019326T3 (no)
HU (2) HUT62606A (no)
IL (3) IL117252A (no)
MX (1) MX9205822A (no)
NO (3) NO304523B1 (no)
NZ (1) NZ244644A (no)
RU (1) RU2095368C1 (no)
SK (1) SK279399B6 (no)
TW (1) TW305846B (no)
UY (2) UY23488A1 (no)
ZA (1) ZA927724B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872803B1 (en) 1993-09-21 2005-03-29 Kyowa Hakko Kogyo Co., Ltd. Peptides
KR100493795B1 (ko) * 1996-02-09 2005-09-09 에프. 호프만-라 로슈 아게 혈관활성장펩타이드유사체의합성방법
DE69738353T2 (de) * 1996-07-12 2009-09-24 Immunomedics, Inc. Radiometall-bindende peptide analoge
WO1998002453A2 (en) * 1996-07-15 1998-01-22 Universite Libre De Bruxelles Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor
ES2307534T3 (es) * 1999-09-28 2008-12-01 Bayer Corporation Agonistas de receptores 3 (r3) del peptido activador de la adenilato ciclasa hipofisiaria (pacap) y sus metodos de uso farmacologicos.
US6972319B1 (en) 1999-09-28 2005-12-06 Bayer Pharmaceuticals Corporation Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use
DE60033697D1 (de) 2000-02-18 2007-04-12 Dabur Res Foundation Sahibabad Radiomarkierte vip-analoge zur diagnose und therapie
WO2001060862A1 (en) 2000-02-18 2001-08-23 Dabur Research Foundation Vasoactive intestinal peptide analogs
US6828304B1 (en) 2000-07-31 2004-12-07 Dabur Research Foundation Peptides for treatment of cancer
US7507714B2 (en) * 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
CN1487952A (zh) 2000-11-28 2004-04-07 �ɶ����＼��ʵ���� 具有血管活性肠肽的生物学活性的用于治疗肺动脉和小动脉高压的化合物
US20060241028A1 (en) 2002-06-10 2006-10-26 Dorian Bevec Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
AU2005208911A1 (en) * 2004-01-27 2005-08-11 Bayer Healthcare Llc Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
US20080085860A1 (en) * 2004-08-18 2008-04-10 Eli Lilly And Company Selective Vpac2 Receptor Peptide Agonists
CA2577010A1 (en) * 2004-08-18 2006-03-02 Eli Lilly And Company Selective vpac2 receptor peptide agonists
BRPI0708341A2 (pt) * 2006-02-28 2011-05-24 Lilly Co Eli agonistas peptìdicos seletivos do receptor vpac2
MX2009000013A (es) * 2006-07-06 2009-01-23 Hoffmann La Roche Nuevos analogos del peptido intestinal vasoactivo.
CN101906144B (zh) * 2009-06-03 2013-06-19 首都医科大学 一根Arg-Gly-Asp-Val链通过Asp与两根脂肪醇链的偶联物、它们的合成及在医学中的应用
EP2464370B1 (en) 2009-08-14 2017-03-29 Phasebio Pharmaceuticals, Inc. Modified vasoactive intestinal peptides
WO2011133948A2 (en) * 2010-04-22 2011-10-27 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
CA2873553C (en) 2011-06-06 2020-01-28 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
WO2014145718A2 (en) 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
GB201421647D0 (en) * 2014-12-05 2015-01-21 Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
CA2976038A1 (en) 2015-02-09 2016-08-18 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating muscle disease and disorders
JP6892867B2 (ja) 2016-09-30 2021-06-23 富士フイルム株式会社 環状ペプチド、アフィニティクロマトグラフィー担体、標識化抗体、抗体薬物複合体および医薬製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
GB8729802D0 (en) * 1987-12-22 1988-02-03 Beecham Group Plc Novel compounds
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5141924A (en) * 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs

Also Published As

Publication number Publication date
FI924580A (fi) 1993-04-12
CN1225473C (zh) 2005-11-02
NZ244644A (en) 1995-04-27
NO304523B1 (no) 1999-01-04
NO980377D0 (no) 1998-01-28
DE69207138T2 (de) 1996-06-13
DK0536741T3 (da) 1996-04-22
GR3019326T3 (en) 1996-06-30
KR970001580B1 (ko) 1997-02-11
MX9205822A (es) 1993-06-01
HUT62606A (en) 1993-05-28
IL103396A (en) 1997-11-20
CN1152579A (zh) 1997-06-25
IL103396A0 (en) 1993-03-15
FI111646B (fi) 2003-08-29
JP2515473B2 (ja) 1996-07-10
DE69207138D1 (de) 1996-02-08
ZA927724B (en) 1994-04-07
CN1034943C (zh) 1997-05-21
SK308692A3 (en) 1995-03-08
FI20002041A (fi) 2000-09-15
NO975023L (no) 1993-04-13
HU9203194D0 (en) 1992-12-28
AU656230B2 (en) 1995-01-27
BG61125B2 (bg) 1996-11-29
HU211534A9 (en) 1995-12-28
BR9203959A (pt) 1993-04-27
UY25084A1 (es) 1998-12-21
CZ308692A3 (en) 1993-08-11
TW305846B (no) 1997-05-21
EP0536741B1 (en) 1995-12-27
RU2095368C1 (ru) 1997-11-10
US5677419A (en) 1997-10-14
KR930007972A (ko) 1993-05-20
CZ281818B6 (cs) 1997-02-12
SK279399B6 (sk) 1998-11-04
IL117252A0 (en) 1996-06-18
NO980377L (no) 1993-04-13
CA2080272A1 (en) 1993-04-12
ES2082317T3 (es) 1996-03-16
AU2622892A (en) 1993-04-22
NO923929D0 (no) 1992-10-09
CN1153785A (zh) 1997-07-09
JPH05213996A (ja) 1993-08-24
IL117252A (en) 1999-11-30
ATE132165T1 (de) 1996-01-15
CN1072415A (zh) 1993-05-26
FI924580A0 (fi) 1992-10-09
NO923929L (no) 1993-04-13
CN1198841C (zh) 2005-04-27
EP0536741A2 (en) 1993-04-14
EP0536741A3 (no) 1994-04-06
UY23488A1 (es) 1993-04-20
CA2080272C (en) 2002-09-17

Similar Documents

Publication Publication Date Title
NO923929D0 (no) Vasoaktive cykliske polypeptider
IL142025A0 (en) Novel methods for displaying (poly) peptides/proteins on bacteriophage particles via disulfide bonds
DK601786A (da) Hidtil ukendte prokoagulationsproteiner
DK0673948T3 (da) Peptider, der stammer fra et retrovirus fra HIV-gruppen, og deres anvendelse
FR2744134B1 (fr) Proteines de reserve de plantes enrichies en acides amines, notamment alpha-zeine de mais enrichie en lysine plantes exprimant ces proteines
IL155693A0 (en) Cyclic peptide analogs of somatostatin
DE69827262D1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
FI964363A0 (fi) Peptidejä
EP0333587A3 (en) Method for purifying and isolating carboxyl-terminal peptides
FI942392A (fi) Peptidejä ja vasta-aineita nivelreuman hoitoon
ATE46173T1 (de) Pharmakologisch aktive peptide.
AU2003260306A1 (en) Bicyclic oligopeptides

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application